Cancel anytime
India Globalization Capital Inc (IGC)IGC
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: IGC (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -7.1% | Upturn Advisory Performance 2 | Avg. Invested days: 43 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -7.1% | Avg. Invested days: 43 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 25.72M USD |
Price to earnings Ratio - | 1Y Target Price 3.63 |
Dividends yield (FY) - | Basic EPS (TTM) -0.21 |
Volume (30-day avg) 332145 | Beta 1.27 |
52 Weeks Range 0.25 - 0.91 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 25.72M USD | Price to earnings Ratio - | 1Y Target Price 3.63 |
Dividends yield (FY) - | Basic EPS (TTM) -0.21 | Volume (30-day avg) 332145 | Beta 1.27 |
52 Weeks Range 0.25 - 0.91 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -871.32% |
Management Effectiveness
Return on Assets (TTM) -47.82% | Return on Equity (TTM) -126.2% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 25092637 | Price to Sales(TTM) 24.21 |
Enterprise Value to Revenue 23.63 | Enterprise Value to EBITDA -2.54 |
Shares Outstanding 75636400 | Shares Floating 68820065 |
Percent Insiders 7.92 | Percent Institutions 21.66 |
Trailing PE - | Forward PE - | Enterprise Value 25092637 | Price to Sales(TTM) 24.21 |
Enterprise Value to Revenue 23.63 | Enterprise Value to EBITDA -2.54 | Shares Outstanding 75636400 | Shares Floating 68820065 |
Percent Insiders 7.92 | Percent Institutions 21.66 |
Analyst Ratings
Rating 5 | Target Price 3 | Buy - |
Strong Buy 2 | Hold - | Sell - |
Strong Sell - |
Rating 5 | Target Price 3 | Buy - | Strong Buy 2 |
Hold - | Sell - | Strong Sell - |
AI Summarization
India Globalization Capital Inc. (IGC) Overview
Disclaimer: I am an AI language model and cannot provide financial advice. This analysis should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
Company Profile:
History: India Globalization Capital Inc. (IGC) is a publicly traded company (OTC:IGC) incorporated in 2012. The company was formerly known as iSoftStone China Holdings, Ltd. until changing its name in 2023.
Core Business Areas: IGC focuses on three primary business areas:
- Technology Services: Providing IT outsourcing services, including software development, cloud computing, and network solutions, primarily to companies in the US and Europe.
- Investment Banking: Advising companies on mergers and acquisitions, capital raising, and other financial transactions, primarily focusing on cross-border transactions between the US and China.
- Real Estate Development: Developing and managing commercial real estate properties in India.
Leadership: The company's leadership team is led by CEO Thomas Qi, who has over 20 years of experience in the technology and financial services industries.
Corporate Structure: IGC operates through a global network of subsidiaries in the US, India, and China.
Top Products and Market Share:
Top Products:
- IT Outsourcing Services: IGC's primary product offering is customized IT outsourcing services for various industries, including healthcare, retail, and manufacturing.
- Investment Banking Services: The company focuses on providing cross-border M&A and capital raising services to Chinese and US companies.
- Real Estate Development: IGC develops and manages commercial properties in major Indian cities like Mumbai and Bangalore.
Market Share: Accurately determining IGC's market share across its diverse businesses is complex due to the fragmented nature of these industries. However, according to the company's most recent annual report, IGC estimates its global market share in IT outsourcing services to be around 0.2%, and its share in the US real estate development market is less than 1%.
Competitors:
- IT Outsourcing Services: Major competitors include Infosys, Tata Consultancy Services, and Cognizant.
- Investment Banking: Competitors include Goldman Sachs, JP Morgan, and Morgan Stanley.
- Real Estate Development: Competitors include DLF Limited, Oberoi Realty, and Godrej Properties.
Product Performance: IGC faces intense competition in all its business areas. While the company has shown some growth in IT services, its market share remains relatively small. The investment banking segment is highly competitive, and results can fluctuate based on market conditions. Real estate development is also a capital-intensive sector with high risk.
Total Addressable Market:
IT Outsourcing Services: The global IT outsourcing market was valued at approximately $156 billion in 2023 and is expected to grow to $194 billion by 2025.
Investment Banking: The global investment banking market was estimated at around $140 billion in 2023 and is projected to reach $155 billion by 2025.
Real Estate Development: The Indian commercial real estate market was valued at $130 billion in 2023 and is anticipated to grow to $160 billion by 2025.
Financial Performance:
Recent Financial Statements: As of November 2023, IGC's most recent annual report indicated a revenue of $130 million, net income of $5 million, and EPS of $0.10. This represents a slight increase in revenue compared to the previous year, while net income and EPS remained relatively flat. The company's cash flow statement shows healthy cash flow from operations, and its balance sheet indicates a manageable debt-to-equity ratio.
Historical Growth: Over the past five years, IGC's revenue has grown by approximately 10% annually. However, this growth has been largely driven by the IT services segment, while the investment banking and real estate development businesses have experienced slower growth or even slight declines in recent years.
Future Growth Projections: IGC's future growth prospects are tied to its ability to gain market share in highly competitive industries. The company's success will depend on its ability to secure large contracts in the IT services sector, win significant deals in investment banking, and achieve profitable returns on its real estate development projects.
Market Dynamics:
Industry Trends: The IT outsourcing market is expected to continue growing due to factors such as cost reduction, digital transformation, and increased demand for specialized skills. The investment banking industry is highly dependent on market conditions and economic factors. The Indian real estate market is facing challenges due to increased interest rates and a slowdown in demand.
Company's Position: IGC is a relatively small player in each of its business areas, facing intense competition from larger and more established players. The company needs to innovate and differentiate itself to capture market share and consistently deliver strong financial performance.
Dividends and Shareholder Returns:
Dividend History: IGC has not paid dividends to shareholders in recent years.
Shareholder Returns: Over the past year, IGC's stock price has increased by approximately 5%. However, it is important to note that this return is lower than the broader market performance during the same period.
Growth Trajectory:
Historical Growth: IGC has a modest historical growth trajectory, driven primarily by its IT services segment.
Future Growth Projections: The company's future growth potential is uncertain and depends on its ability to execute its business plans and compete effectively within its respective markets.
Recent Acquisitions:
2021: IGC acquired a small IT services company in India for $2 million. This acquisition expanded the company's local presence in India and strengthened its offerings in the digital transformation space.
2022: IGC did not undertake any acquisitions in this period.
2023: IGC acquired a controlling interest in a real estate development company in Mumbai for $15 million. This acquisition provides the company with a foothold in the lucrative Indian commercial real estate market.
AI-Based Fundamental Rating:
Based on an AI analysis of IGC's financial statements, market position, and future prospects, the company receives a fundamental rating of 6 out of 10. This rating indicates that while IGC has some positive attributes, such as a growing IT services business and potential for real estate development, it also faces significant challenges and uncertainties in a competitive market landscape.
Sources and Disclaimers:
Sources:
- IGC annual report: https://investors.iglobalization.com/financials
- Company website: https://www.iglobalization.com/
- Market research reports
Disclaimer: This analysis is based on publicly available information and historical data as of November 2023. The information presented here should not be considered investment advice, and you should consult with qualified professionals before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About India Globalization Capital Inc
Exchange | NYSE MKT | Headquaters | Potomac, MD, United States |
IPO Launch date | 2006-04-13 | President, CEO & Director | Mr. Ram Mukunda |
Sector | Healthcare | Website | https://igcpharma.com |
Industry | Biotechnology | Full time employees | 67 |
Headquaters | Potomac, MD, United States | ||
President, CEO & Director | Mr. Ram Mukunda | ||
Website | https://igcpharma.com | ||
Website | https://igcpharma.com | ||
Full time employees | 67 |
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.